Status:
COMPLETED
Long-term Clinical Follow-up After PCI for CTO
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Coronary Total Occlusion
Eligibility:
All Genders
18+ years
Brief Summary
The research aimed to evaluate the impact of a successful Percutaneous coronary intervention of chronic total occlusions (CTO-PCI) on long-term MACE (Major Cardiovascular Events), symptoms, survival, ...
Detailed Description
With this observational and prospective study, this research aimed to evaluate the impact of a successful CTO-PCI on long-term MACE (Major Cardiovascular Events), symptoms, survival, LVEF and myocardi...
Eligibility Criteria
Inclusion
- 18 years or older
- who underwent at least one CTO procedure between 2025 and 2022 in Montpellier University Hospital
- symptomatic of reversible myocardial ischemia
- proof of myocardial viability
Exclusion
- refusal of the patient to participate to the study
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2024
Estimated Enrollment :
448 Patients enrolled
Trial Details
Trial ID
NCT06544174
Start Date
November 1 2023
End Date
May 1 2024
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Montpellier, France, 34090